Neurocrine biosciences set to join s&p midcap 400; o-i glass to join s&p smallcap 600

New york, march 24, 2021 /prnewswire/ -- neurocrine biosciences inc. (nasd:nbix) will replace o-i glass inc. (nyse:oi) in the s&p midcap 400, and o-i glass will replace hms holdings corp (nasd:hmsy) in the s&p smallcap 600 effective prior to the opening of trading on tuesday, march 30. veritas capital is acquiring hms holding in a deal expected to be completed soon pending final conditions.
NBIX Ratings Summary
NBIX Quant Ranking